Bictegravir 相關新聞

← 返回新聞總覽


Bictegravir 目前有 0 則相關新聞報導,預測適應症 20 個。

本頁整合 Bictegravir 的 AI 預測適應症與最新健康新聞,橘色標示的適應症表示近期有相關新聞報導。
藥物資訊
  • 原適應症:Biktarvy is indicated for the treatment of human immunodeficiency virus 1 (HIV 1) infection in adults and paediatric patients at least 2 years of age and weighing at least 14 kg i without present or...
  • 證據等級:L5
  • 預測適應症(20 個):
    • HIV infectious disease(99.9%)
    • simian immunodeficiency virus infection(99.8%)
    • feline acquired immunodeficiency syndrome(99.8%)
    • neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter(99.8%)
    • AIDS(97.3%)
    • chronic hepatitis C virus infection(95.5%)
    • AIDS related complex(94.8%)
    • congenital human immunodeficiency virus(94.8%)
    • hepatitis C virus infection(93.3%)
    • hepatitis E virus infection(92.1%)
    • hepatitis A virus infection(91.9%)
    • Omsk hemorrhagic fever(91.8%)
    • Kyasanur forest disease(91.7%)
    • hepatitis, viral, animal(91.6%)
    • ulceration of vulva(90.7%)
    • anogenital human papillomavirus infection(90.3%)
    • fibroma of prostate(90.2%)
    • Brenner tumor(90.2%)
    • vulvitis(90.0%)
    • vulvar neoplasm(90.0%)

查看完整藥物報告 →

相關新聞(0 則)

目前沒有相關新聞報導。當有新聞提到此藥物時,系統會自動收集並顯示在這裡。

免責聲明:本頁新聞由系統自動收集,僅供研究參考,不構成醫療建議。

Copyright © 2026 EuTxGNN Project. For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.